• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

是否有可能减少硬皮病皮肤评分评估中的观察者变异性?硬皮病疾病结局评估特设国际小组。

Is it possible to reduce observer variability in skin score assessment of scleroderma? The ad hoc International Group on the Assessment of Disease Outcome in Scleroderma.

作者信息

Silman A, Harrison M, Brennan P

机构信息

Arthritis and Rheumatism Council Epidemiology Research Unit, University of Manchester, UK.

出版信息

J Rheumatol. 1995 Jul;22(7):1277-80.

PMID:7562758
Abstract

OBJECTIVE

A total skin thickness score based on summating the numerical severity grade at a specific number of skin sites is a widely accepted method of disease assessment in scleroderma. Our aim was to simplify the modified Rodnan skin thickness score (grade 0-3 at 17 sites) by either (1) reducing the number of grades or (2) reducing the number of sites, and to increase agreement without losing precision.

METHODS

Eight patients were examined in random order by 16 experienced clinicians using the modified Rodnan method. The data were analyzed to determine (1) whether there was an improvement in agreement by reducing severity grades to a 0-2 scale, (2) whether the precision of the score could be maintained by using a reduced number of sites.

RESULTS

Collapsing adjacent grades from the 0-3 scale to generate 3 new 0-2 scales performed similarly (intraclass correlation coefficients 0.66-0.72). A regression analysis showed that 95% of the variance in skin score can be predicted by inclusion of scores from just 5 sites: forearms, lower legs, anterior chest, upper arms, and fingers.

CONCLUSION

A simpler skin score may be useful in clinical studies depending on the precision required.

摘要

目的

基于特定数量皮肤部位的数值严重程度分级总和得出的全皮肤厚度评分,是硬皮病疾病评估中一种广泛接受的方法。我们的目标是通过以下两种方式简化改良的罗德南皮肤厚度评分(17个部位,分级为0 - 3级):(1)减少分级数量;(2)减少部位数量,并在不损失精度的情况下提高一致性。

方法

16名经验丰富的临床医生按照随机顺序,使用改良的罗德南方法对8名患者进行检查。对数据进行分析,以确定:(1)将严重程度分级简化为0 - 2级是否能提高一致性;(2)使用较少数量的部位能否保持评分的精度。

结果

将0 - 3级中的相邻分级合并以生成3个新的0 - 2级,其表现相似(组内相关系数为0.66 - 0.72)。回归分析表明,仅纳入前臂、小腿、前胸、上臂和手指这5个部位的评分,就能预测皮肤评分中95%的方差。

结论

根据所需精度,更简单的皮肤评分在临床研究中可能有用。

相似文献

1
Is it possible to reduce observer variability in skin score assessment of scleroderma? The ad hoc International Group on the Assessment of Disease Outcome in Scleroderma.是否有可能减少硬皮病皮肤评分评估中的观察者变异性?硬皮病疾病结局评估特设国际小组。
J Rheumatol. 1995 Jul;22(7):1277-80.
2
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.系统性硬化症中总皮肤厚度评分(改良Rodnan TSS)的观察者间和观察者内变异性。
J Rheumatol. 1995 Jul;22(7):1281-5.
3
Variability of skin scores and clinical measurements in scleroderma.硬皮病中皮肤评分和临床测量的变异性。
J Rheumatol. 1995 Jul;22(7):1271-6.
4
Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.系统性硬化症的皮肤厚度评分:三项独立研究中观察者间变异性的评估
J Rheumatol. 1993 Nov;20(11):1892-6.
5
Durometry for the assessment of skin disease in systemic sclerosis.用于评估系统性硬化症皮肤疾病的硬度计检查
Arthritis Rheum. 2006 Aug 15;55(4):603-9. doi: 10.1002/art.22093.
6
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.甲氨蝶呤与安慰剂治疗早期弥漫性硬皮病的随机对照试验。
Arthritis Rheum. 2001 Jun;44(6):1351-8. doi: 10.1002/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I.
7
Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.弥漫性皮肤系统性硬化症中皮肤评分变化与疾病转归的关系:潜在线性轨迹模型的应用
Arthritis Rheum. 2007 Jul;56(7):2422-31. doi: 10.1002/art.22721.
8
The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.改良的罗德南皮肤评分是系统性硬化症中皮肤活检厚度的准确反映。
J Rheumatol. 1998 Jan;25(1):84-8.
9
Lack of relationship between functional ability and skin score in patients with systemic sclerosis.系统性硬化症患者的功能能力与皮肤评分之间缺乏相关性。
J Rheumatol. 2001 Feb;28(2):292-5.
10
The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma.健康评估问卷(HAQ)对早期弥漫性硬皮病的良好预后具有很强的预测性:两项早期弥漫性硬皮病随机对照试验的分析结果
Rheumatology (Oxford). 2004 Apr;43(4):472-8. doi: 10.1093/rheumatology/keh070. Epub 2003 Dec 16.

引用本文的文献

1
Traditional medicine meets modern science: Halofuginone's role in combating autoimmune diseases.传统医学与现代科学相遇:常山酮在对抗自身免疫性疾病中的作用。
J Nat Med. 2025 Jun 30. doi: 10.1007/s11418-025-01927-1.
2
Deep Learning Classification of Systemic Sclerosis Skin Using the MobileNetV2 Model.使用MobileNetV2模型对系统性硬化症皮肤进行深度学习分类
IEEE Open J Eng Med Biol. 2021 Mar 17;2:104-110. doi: 10.1109/OJEMB.2021.3066097. eCollection 2021.
3
Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
硬皮病的临床治疗选择:建议和综合评价。
Clin Rev Allergy Immunol. 2022 Apr;62(2):273-291. doi: 10.1007/s12016-020-08831-4. Epub 2021 Jan 15.
4
How much of skin improvement over time in systemic sclerosis is due to normal ageing? A prospective study with shear-wave elastography.系统性硬化症患者皮肤随时间改善的程度有多少归因于正常老化?一项应用剪切波弹性成像的前瞻性研究。
Arthritis Res Ther. 2020 Mar 18;22(1):50. doi: 10.1186/s13075-020-02150-x.
5
Assessment of light touch sensation in the hands of systemic sclerosis patients.系统性硬化症患者手部轻触觉评估。
Clinics (Sao Paulo). 2014 Sep;69(9):585-8. doi: 10.6061/clinics/2014(09)02.
6
Biomarkers in the management of scleroderma: an update.硬皮病管理中的生物标志物:更新。
Curr Rheumatol Rep. 2011 Feb;13(1):4-12. doi: 10.1007/s11926-010-0140-z.
7
The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.局限性硬皮病皮肤严重指数和医生对疾病活动的总体评估:开发局限性硬皮病结局指标的进展情况。
J Rheumatol. 2009 Dec;36(12):2819-29. doi: 10.3899/jrheum.081284. Epub 2009 Oct 15.
8
Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials.弥漫性系统性硬化症中改良罗德南皮肤评分对变化的敏感性——两项大型随机对照试验中个体身体部位的评估
Rheumatology (Oxford). 2009 Sep;48(9):1143-6. doi: 10.1093/rheumatology/kep202. Epub 2009 Jul 14.
9
The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis.用于系统性硬化症中教授和实施改良罗德南皮肤评分的EUSTAR模型。
Ann Rheum Dis. 2007 Jul;66(7):966-9. doi: 10.1136/ard.2006.066530. Epub 2007 Jan 18.